Corporate & Financial Strategy
  Investor Relations
  Financial Communications

EJ Palmer Consulting

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

EJPC has worked with NeRRE Therapeutics on media relations and conference presentations.

Pulmagen Therapeutics is a privately held respiratory drug development company headquartered in Burnham, Bucks, UK.

EJPC worked with Pulmagen Therapeutics on media relations as part of a business development campaign.

STORM Therapeutics is a pioneer in the field of RNA epigenetics. It is an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

EJPC worked with Storm Therapeutics on establishing its key messages, branding and corporate presentation following its successful Series A fundraising.

Jupiter Diagnostics has developed a reader which allows anyone to perform blood tests quickly and affordably

EJPC helped Jupiter Diagnostics to refine its key messages during a phase of rapid development.

EJ Palmer Consulting worked on a communications, marketing and market access strategy for Exploristics.

EJ Palmer Consulting is working with The Oxford Science Park to raise its profile in the life sciences and technology sectors, and across the County of Oxfordshire.

EJ Palmer Consulting worked with KaNDy Therapeutics on its launch messages, communications and website.

EJ Palmer Consulting provided an analysis of the UK science park sector and advised Bulb Laboratories on communications and marketing.

EJ Palmer Consulting is working with VivoPlex on business development profile raising post its Series A fundraising. This includes messaging, press releases and a revised website.

EJ Palmer Consulting is helping Discovery Park raise its profile in the UK life sciences sector as it builds a successful science park.

Page 3 of 4